Drug Facts
Composition & Profile
Identifiers & Packaging
HOW SUPPLIED Triamcinolone Acetonide Ointment USP, 0.1% is available as follows: 15 g tube NDC 68462-797-17 80 g tube NDC 68462-797-49 454 g jar NDC 68462-797-59 Triamcinolone Acetonide Ointment USP, 0.5% is available as follows: 15 g tube NDC 68462-798-17 Storage Store at 20° to 25°C (68° to 77°F); [See USP Controlled Room Temperature] Manufactured by: Glenmark Pharmaceuticals Limited Village Kishanpura, Baddi Nalagarh Road, District: Solan, Himachal Pradesh 173205, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 Questions? 1 (888)721-7115 www.glenmarkpharma.com/usa December 2016; PACKAGE LABEL DISPLAY PANEL Triamcinolone_0.1%_80g_Tube; PACKAGE LABEL DISPLAY PANEL Triamcinolone_0.1%_80g_Carton; PACKAGE LABEL DISPLAY PANEL Triamcinolone_0.1%_454g_Jar; PACKAGE LABEL DISPLAY PANEL tube-1; PACKAGE LABEL DISPLAY PANEL carton-1
- HOW SUPPLIED Triamcinolone Acetonide Ointment USP, 0.1% is available as follows: 15 g tube NDC 68462-797-17 80 g tube NDC 68462-797-49 454 g jar NDC 68462-797-59 Triamcinolone Acetonide Ointment USP, 0.5% is available as follows: 15 g tube NDC 68462-798-17 Storage Store at 20° to 25°C (68° to 77°F); [See USP Controlled Room Temperature] Manufactured by: Glenmark Pharmaceuticals Limited Village Kishanpura, Baddi Nalagarh Road, District: Solan, Himachal Pradesh 173205, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 Questions? 1 (888)721-7115 www.glenmarkpharma.com/usa December 2016
- PACKAGE LABEL DISPLAY PANEL Triamcinolone_0.1%_80g_Tube
- PACKAGE LABEL DISPLAY PANEL Triamcinolone_0.1%_80g_Carton
- PACKAGE LABEL DISPLAY PANEL Triamcinolone_0.1%_454g_Jar
- PACKAGE LABEL DISPLAY PANEL tube-1
- PACKAGE LABEL DISPLAY PANEL carton-1
Overview
The topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents. The steroids in this class include triamcinolone acetonide. Triamcinolone acetonide USP is designated chemically as 9-Fluoro-11, 16, 17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone. Structural Formula: C 24 H 31 FO 6 , MW 434.50 Each gram of 0.1% and 0.5% Triamcinolone Acetonide Ointment USP contains 1 mg or 5 mg triamcinolone acetonide, respectively, in an ointment base of light mineral oil and white petrolatum. Triamcinolone Acetonide Structure
Indications & Usage
Triamcinolone Acetonide Ointment 0.1% and 0.5% are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage & Administration
Apply a thin film of Triamcinolone Acetonide Ointment USP, 0.1% or 0.5%, as appropriate, to the affected area two to three times daily. Occlusive Dressing Technique Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions. Apply a thin film of ointment to the lesion, cover with a pliable nonporous film, and seal the edges. If needed, additional moisture may be provided by covering the lesion with a dampened clean cotton cloth before the nonporous film is applied or by briefly wetting the affected area with water immediately prior to applying the medication. The frequency of changing dressings is best determined on an individual basis. It may be convenient to apply triamcinolone acetonide ointment under an occlusive dressing in the evening and to remove the dressing in the morning (i.e., 12-hour occlusion). When utilizing the 12-hour occlusion regimen, additional ointment should be applied, without occlusion, during the day. Reapplication is essential at each dressing change. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
Warnings & Precautions
No warnings available yet.
Contraindications
Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.
Adverse Reactions
The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings (reactions are listed in an approximate decreasing order of occurrence): burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.
Similar Drugs
Related medications based on brand, generic name, substance, active ingredients.